✦ LIBER ✦

PND9 THE COST-EFFECTIVENESS OF NATALIZUMAB IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS

✍ Scribed by K Meyer; E Chiao

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost effectiveness and budget impact of

✍ Chiao, Evelyn; Meyer, Kellie 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 170 KB

Cost-effectiveness of natalizumab versus

✍ O’Day, Ken; Meyer, Kellie; Miller, Ross M.; Agarwal, Sonalee; Franklin, Meg 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 373 KB

PND33 Cost Minimization Analysis of Fing

✍ B. Verheggen; M. Treur; M. Groot 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PND6 COST-EFFECTIVENESS OF GLATIRAMER AC

✍ JB Graham; SR Earnshaw; J Castelli-Haley; M Oleen-Burkey; KP Johnson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PND19 AT ALIZUMAB REDUCES RELAPSE-ASSOCI

✍ K O'Day; K Meyer; K Rajagopalan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Natalizumab use in pediatric patients wi

✍ Arnal-Garcia, Carmen; García-Montero, Ma. Rosa; Málaga, Ignacio; Millán-Pascual, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 169 KB